StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)

Close on Nov 17, 2026Market cap $6.18MP/E –Yield –

Quantum Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Quantum Biopharma

Quantum Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Quantum Biopharma figures

See a number that looks wrong?